Trafalgar International (GCAN) EBITDA (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly EBITDA of -$33376.0 for Q1 2026, up 23.34% year-over-year from -$27060.8 in Q1 2025, and up 37.97% quarter-over-quarter from -$53806.0 in Q4 2025.
Trafalgar International (GCAN) EBITDA (2017 - 2026) Analysis & Trends
Greater Cannabis Company's EBITDA history runs 10 years deep, the most recent figure standing at -$33376.0 for Q1 2026.
- In Q1 2026, EBITDA rose 23.34% year-over-year to -$33376.0; the TTM figure through Mar 2026 stood at -$172845.0 (down 7.45% YoY), while the FY2025 annual figure was -$183005.0, down 17.1% from the prior year.
- EBITDA for Q1 2026 stood at -$33376.0, up from -$53806.0 in the prior quarter.
- The five-year high for EBITDA was -$33376.0 in Q1 2026, with the low at -$53806.0 in Q4 2025.
- The 5-year median for EBITDA is -$42267.0 (2022), against an average of -$42650.4.
- The sharpest annual moves came in 2022 and 2025: EBITDA surged 64.81% in 2022, then sank 43.01% in 2025.
- Greater Cannabis Company's EBITDA stood at -$42267.0 in 2022, then declined by 4.16% to -$44027.0 in 2023, then increased by 14.54% to -$37625.0 in 2024, then tumbled by 43.01% to -$53806.0 in 2025, then surged by 37.97% to -$33376.0 in 2026.
- Business Quant data shows GCAN's EBITDA at -$33376.0 in Q1 2026, -$53806.0 in Q4 2025, and -$37412.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | -33,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,376.00 |
| Dec 31, 2025 | -53,806.00 |
| Sep 30, 2025 | -37,412.00 |
| Jun 30, 2025 | -48,251.00 |
| Mar 31, 2025 | -43,536.00 |
| Dec 31, 2024 | -37,625.00 |
| Sep 30, 2024 | -40,443.00 |
| Jun 30, 2024 | -39,257.00 |
| Mar 31, 2024 | -38,951.00 |
| Dec 31, 2023 | -44,027.00 |
| Sep 30, 2023 | -50,465.00 |
| Jun 30, 2023 | -41,404.00 |
| Mar 31, 2023 | -39,468.00 |
| Dec 31, 2022 | -42,267.00 |
| Sep 30, 2022 | -49,304.00 |
| Jun 30, 2022 | -43,034.00 |
| Mar 31, 2022 | -42,430.00 |
| Dec 31, 2021 | -120,102.00 |
| Sep 30, 2021 | -74,338.00 |
| Jun 30, 2021 | -62,474.00 |